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cardial ischemia during sexual activity than nitrates alone (-45+11% vs –18+7%, p<0.04).
In conclusion patients with cardiovascular disease receiving chronic nitrate therapy may
be safely switched to Trimetazidine in case of need of therapy for ED. The association
between Sildenafil and Trimetazidine is more effective than nitrate therapy in the control
of ischemic episodes during sexual activity.
1023-95 Excessive Bleeding With Aspirin, Clopidogrel, and 
Warfarin "Triple Therapy"
Adam B. Greenbaum, Ghadi G. Ghorayeb, Michael P. Hudson, Laila M. Poisson, W. 
Douglas Weaver, Henry Ford Heart and Vascular Institute, Detroit, MI
Background: Numerous medical conditions require patients to receive chronic anti-
thrombin therapy. Recent guidelines support longer and more aggressive antiplatelet
therapy after myocardial infarction (MI) and following drug-eluting stent implantation or
intravascular radiation. Currently, there is no safety data supporting or warning against
the use of "triple therapy" with aspirin, clopidogrel and warfarin and practice patterns
vary. Our aim was to estimate the risk and severity of bleeding complications in patients
receiving "triple therapy". Methods: Via electronic medical records search, 110 patients
either discharged on or receiving >2 consecutive days of "triple therapy" while hospital-
ized were identified and data collected regarding baseline demographics and laboratory
values, indication for therapy and bleeding complications. Comparisons were made
between those with and without bleeding and to historical controls. Results: The overall
population was representative of those requiring antiplatelet and/or antithrombin therapy;
mean age 68+12, 63% male; 47% prior MI; 19% prior stroke. Indication for warfarin: 35%
atrial fibrillation; 35% apical thrombus/low ejection fraction. Indication for antiplatelet ther-
apy: 70% PCI; 20% acute coronary syndrome. Bleeding occurred in 25 (23%) of patients;
14% TIMI major; 9% TIMI minor; 6% gastrointestinal; 1% intracranial; median time to
major bleeding: 7 (5, 18) days. Patients who bled were more likely to be female, non-
smokers, have renal insufficiency and a prior stroke. No differences were noted in indica-
tion for therapy, aspirin dose, baseline labs or peak INR between those with and without
bleeding (mean INR at time of bleed; 1.8+1.3). Conclusion: This is the first and only
known estimate of the clinical bleeding risk on "triple therapy" with aspirin, clopidogrel
and warfarin. There appears to be a significantly greater and excessive overall and TIMI
major bleeding risk compared to historical controls with mono- or dual therapy (23% vs 1-
10% and 14% vs 1-4%, respectively, p<0.0001). This was independent of aspirin dose
and INR level. Confirmation is warranted as the implications are vast.
1023-96 A Randomized Double-Blind Placebo-Controlled Phase 
2 Study on the Efficacy and Safety of Fasudil in Patients 
With Stable Angina
Ralph M. Vicari, Bernard Chaitman, Deborah Keefe, William B. Smith, Steven G. 
Chrysant, Melvin J. Tonkon, Neville Bittar, Robert J. Weiss, Udho Thadani, The Fasudil 
Study Group, St. Louis University School of Medicine, St. Louis, MO, University of 
Oklahoma, Oklahoma City, OK
Background: Fasudil, an orally available rho-kinase inhibitor, selectively inhibits coro-
nary arterial vasoconstriction without affecting systemic hemodynamics. Therapeutic
doses in patients with stable angina have not been previously determined.
Methods: In a phase II, multicenter, double-blind, placebo-controlled randomized trial,
we evaluated the effects of fasudil on total exercise duration and time to onset of myocar-
dial ischemia (> 1 mm ST-segment change) in patients with stable angina. Anti-anginal
medications were limited to nitroglycerin prn and monotherapy with either a beta- or cal-
cium-channel blocker. Cardiovascular medications including aspirin, statins, and ACE
inhibitors were allowed. Patients of either sex were required to have objective evidence of
myocardial ischemia, reproducible baseline exercise test times, and exercise-induced ST
segment depression > 1 mm. A total of 84 of the 206 patients screened met entry criteria
and were randomized 1:1 to placebo or fasudil for efficacy analysis. After a 3-week wash-
out period, fasudil or matching placebo were force-titrated from 20 mg tid to 80 mg tid
with 20 mg tid increments every 2 weeks. Efficacy was evaluated by symptom-limited
exercise testing after eight weeks of therapy.
Results: Exercise duration at 8 weeks was increased by 1.43 min (86.1 seconds) in the
placebo group, and by 1.97 min (118.4 seconds) in the fasudil group (both p<0.001 vs
baseline and p=ns to each group). Time to onset of myocardial ischemia was increased
by 2.83 min in the fasudil group compared to placebo at 8 weeks (p=0.012). Heart rate
and blood pressure were unchanged in both groups. A 10% discontinuation rate due to
adverse events was evenly divided between the two groups.
Conclusions: This dose-finding trial demonstrated that titrating fasudil to 80 mg tid
improves exercise time and time to exercise-induced myocardial ischemia in stable
angina patients, and is well tolerated.
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1041-89 Oxygen Free Radical Damage to Essential Components 
of the Oxidative Phosphorylation Pathway
Melanie Y. White, Stuart J. Cordwell, Hugh C.K. McCarron, Adrian S. Tchen, Brett D. 
Hambly, Richmond W. Jeremy, The University of Sydney, The University of Sydney, 
Australia, Australian Proteome Analysis Facility, Macquarie University, Australia
Background: Stunned myocardium is characterized by impaired contractile function, and
oxygen free radicals (OFR) are known to contribute to the pathogenesis. Oxidative phos-
phorylation is maintained in stunning, but abnormal phosphate / oxygen (P/O) ratios sug-
gest limited uncoupling of electron transport. Recent studies have shown mitochondria
are particularly sensitive to damage resulting from ischemia / reperfusion injury.
Methods: Left ventricular (LV) samples were taken from rabbit hearts after 75 min nor-
mal perfusion (control; n=6) or 15 min low flow (1 ml/min) ischemia followed by 60 min
reperfusion (stunned; n=6). A third group underwent 15I/60R with the hydroxyl radical
scavenger, N-(2-mercaptopropionyl) glycine (3 mM) added to the perfusate (15I/
60R+MPG; n=6). Isovolumic LV pressure was measured throughout. Whole cell protein
profiles were generated by two-dimensional gel electrophoresis and image analysis used
to identify differentially expressed proteins, with mass spectrometry to identify proteins
and define modifications.
Results: Rate pressure product at the end of the protocol was impaired in 15I/60R
(61+6% baseline) in comparison to control (90±6%, mean + SEM; p>1.5-fold difference
in visible abundance). 42 proteins were shown to be modified in 15I/60R samples, 15 of
which were functionally associated with redox metabolism, including 5 NADH ubiquinone
oxidoreductase subunits, cytochrome c reductase and oxidase and two ATP synthase
subunits. Treatment with MPG reversed the majority (n=13/15) of the observed modifica-
tions, but not that seen for NADH Uq 27kDa.
Discussion: Ischemia / reperfusion is associated with multiple alterations to mitochon-
drial electron transport system proteins and the ATP proton pump, which are prevented
by treatment with MPG. The change to NADH Uq 27kDa was not as pronounced follow-
ing the addition of MPG suggesting a two stage insult to this subunit occurring in both the
ischemic and reperfusion periods. These data demonstrate another mechanism by which
OFR contribute to dysfunction of reperfused myocardium.
1041-90 Opening of the Mitochondrial Potassium Adenosine 
Triphosphate Channel Improves Postanoxic Recovery 
of Conduction and Excitation-Contraction Coupling in 
the Developing Heart
Sarre Alexandre, Lange Norbert, Kucera Pavel, Eric Raddatz, Institute of Physiology, 
Lausanne, Switzerland
Background: Activation of the mitochondrial KATP (mitoKATP) channel is thought to pre-
condition the adult heart via ROS production. To what extent modulation of mitoKATP
channel alter oxidative stress and activity of the hypoxic-reoxygenated developing heart
is not known.
Methods: Spontaneously beating hearts were dissected from 4-day-old chick embryos,
mounted in vitro and submitted to 45 min normoxia (21% O2), 30 min anoxia (0% O2)
and 60 min reoxygenation (21% O2) at 37°C. The time-course of ROS production in the
ventricle was determined by measuring changes in fluorescence resulting from oxidation
of the intracellular probe DCFH (10 µM) and expressed as arbitrary units per second
(a.u./s). Involvement of the mitoKATP channel in oxidative stress was assessed by using
the opener diazoxide (DIAZO, 50µM) or the blocker 5-hydroxydecanoate (5-HD, 500 µM).
The nonselective KATP channel blocker Glibenclamide (Glib, 1µM) was also tested. Elec-
trocardiogram and atrial and ventricular contractions were continuously recorded during
experiments. Reoxygenation-induced chrono-, dromo- and inotropic disturbances,
arrhythmias and alterations of electromechanical delay (EMD) in atrium and ventricle
were systematically investigated.
Results: Under normoxia, heart rate (169 ± 24 bpm), PR interval (128 ± 20 ms), ventricu-
lar shortening velocity (1.9 ± 1.3 mm/s), atrial EMD (14 ± 3 ms) and ventricular EMD (9 ±
2 ms) (mean ± SD, n= 6) were similar in all groups. ROS production in control hearts was
0.18 ± 0.06 under normoxia and peaked at 1.02 ± 0.37 a.u./s (n= 6) after 10 min of reox-
ygenation. With respect to control, DIAZO, 5-HD, DIAZO+5-HD or Glib altered neither
ROS production nor functional parameters under steady normoxia. During reoxygen-
ation, 5-HD alone or Glib had no effect, while DIAZO doubled the burst of free radicals
and increased the rate of recovery of PR interval and ventricular EMD. This DIAZO-
induced protection was abolished by 5-HD.
Conclusion: In the developing heart, unlike in adult, it appears that pharmacological acti-
vation of the mitoKATP channel is prooxidant and improves atrio-ventricular conduction
and ventricular excitation-contraction coupling specially during reoxygenation.
